Previous Article | Next Article 
Infect Immun. 1990 March; 58(3): 833-834
Murine gamma interferon fails to inhibit Toxoplasma gondii growth in murine fibroblasts.
J D Schwartzman,
S L Gonias and
E R Pfefferkorn
Department of Pathology, University of Virginia School of Medicine, Charlottesville 22908.
ABSTRACT
Although treatment of human macrophages or fibroblasts with human gamma interferon results in the inhibition of intracellular Toxoplasma gondii, murine gamma interferon stimulated only murine macrophages, not murine fibroblasts, to inhibit T. gondii. This species difference may be important in understanding the control of acute and chronic toxoplasmosis.
Infect Immun. 1990 March; 58(3): 833-834
This article has been cited by other articles:
-
Silva, N. M., Rodrigues, C. V., Santoro, M. M., Reis, L. F. L., Alvarez-Leite, J. I., Gazzinelli, R. T.
(2002). Expression of Indoleamine 2,3-Dioxygenase, Tryptophan Degradation, and Kynurenine Formation during In Vivo Infection with Toxoplasma gondii: Induction by Endogenous Gamma Interferon and Requirement of Interferon Regulatory Factor 1. Infect. Immun.
70: 859-868
[Abstract]
[Full Text]
-
Yap, G. S., Sher, A.
(1999). Effector Cells of Both Nonhemopoietic and Hemopoietic Origin Are Required for Interferon (IFN)-gamma - and Tumor Necrosis Factor (TNF)-alpha -dependent Host Resistance to the Intracellular Pathogen, Toxoplasma gondii. J. Exp. Med.
189: 1083-1092
[Abstract]
[Full Text]
-
Scharton-Kersten, T. M., Yap, G., Magram, J., Sher, A.
(1997). Inducible Nitric Oxide Is Essential for Host Control of Persistent but Not Acute Infection with the Intracellular Pathogen Toxoplasma gondii. J. Exp. Med.
185: 1261-1274
[Abstract]
[Full Text]
Copyright © 1990 by the American Society for Microbiology. All rights reserved.